Olfactory identification deficits and MCI in a multi-ethnic elderly community sample

Neurobiology of Aging

Volumn 31, Issue 9, 2010, Pages 1593-1600

  Devanand, D P ^a   Tabert, Matthias H ^a   Cuasay, Katrina ^a   Manly, Jennifer J ^a,b   Schupf, Nicole ^a,b,c   Brickman, Adam M ^a,b   Andrews, Howard ^c   Brown, Truman R ^a,d   DeCarli, Charles ^e   Mayeux, Richard ^a,b,c  

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NONE   (United States)

^d NONE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Entorhinal cortex volume; Epidemiology; Ethnicity; Hippocampal volume; Mild cognitive impairment; Olfaction; Verbal recall

Indexed keywords

AGE; AGED; AMNESIA; ARTICLE; BOSTON NAMING TEST; BRAIN ATROPHY; BRAIN SIZE; COMMUNITY SAMPLE; CONTROLLED STUDY; EDUCATIONAL STATUS; ELDERLY CARE; ENTORHINAL CORTEX; ETHNIC DIFFERENCE; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; RECALL; SENSORY SYSTEM EXAMINATION; SEX DIFFERENCE; SMELLING DISORDER; UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST;

EID: 77954960034     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.008     Document Type: Article

References (44)

1. Ahmad A.T., Jbara M.A., Hiyasat D., Bateiha A., Ajlouni K.M. The standard clinical smell testing protocol of the National Center for Diabetes, Endocrinology and Genetics in Amman, Jordan: JOR test. Am. J. Otolaryngol. 2007, 28:388-391.
2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. American Psychiatric Association, Washington, D.C.
3. Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 1968, 114:797-811.
4. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 1998, 53:127-140.
5. Brickman A.M., Schupf N., Manly J.J., Luchsinger J.A., Andrews H., Tang M.X., Reitz C., Small S.A., Mayeux R., DeCarli C., Brown T.R. Brain morphology in elderly African Americans, Caribbean Hispanics, and Caucasians from Northern Manhattan. Arch. Neurol. 2008, 65:1053-1061.
6. de Rijk M.C., Rocca W.A., Anderson D.W., Melcon M.O., Breteler M.M., Maraganore D.M. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997, 48:1277-1281.
7. DeCarli C., Murphy D.G., Tranh M., Grady C.L., Haxby J.V., Gillette J.A., Salerno J.A., Gonzales-Aviles A., Horwitz B., Rapoport S.I. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995, 45:2077-2084.
8. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K., Bell K., Stern Y., Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am. J. Psychiatry 2000, 157:1399-1405.
9. Doty R.L. The Smell Identification Test Administration Manual 1995, Sensonics, Haddon Heights, New Jersey.
10. Doty R.L., Shaman P., Applebaum S.L., Giberson R., Siksorski L., Rosenberg L. Smell identification ability: changes with age. Science 1984, 226(4681):1441-1443.
11. Doty R.L., Applebaum S., Zusho H., Settle R.G. Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia 1985, 23:667-672.
12. Doty R.L., Reyes P.F., Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res. Bull. 1987, 18(5):597-600.
13. Doty R.L., Frye R.E., Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept. Psychophys. 1989, 45:381-384.
14. Doty R.L., Perl D.P., Steele J.C., Chen K.M., Pierce J.D., Reyes P., Kurland L.T. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics 1991, 46(Suppl 1):47-51.
15. Doty R.L., Marcus A., Lee W.W. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996, 106:353-356.
16. Duff K., McCaffrey R.J., Solomon G.S. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. J. Neuropsychiatry Clin. Neurosci. 2002, 14(2):197-201.
17. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16(14):4491-4500.
18. Graves A.B., Bowen J.D., Rajaram L., McCormick W.C., McCurry S.M., Schellenberg G.D., Larson E.B. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999, 53(7):1480-1487.
19. Gray A.J., Staples V., Murren K., Dhariwal A., Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 2001, 16(5):513-517.
20. Handley O.J., Morrison C.M., Miles C., Bayer A.J. ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults. Neurobiol. Aging 2006, 27:1425-1430.
21. Hyman B.T., Arriagada P.V., Van Hoesen G.W. Pathologic changes in the olfactory system in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1991, 640:14-19.
22. Killiany R.J., Hyman B.T., Gomez-Isla T., Moss M.B., Kikinis R., Jolesz F., Tanzi R., Jones K., Albert M.S. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002, 58:1188-1196.
23. Kovacs T., Cairns N.J., Lantos P.L. Beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol. Appl. Neurobiol. 1999, 25(6):481-491.
24. Manly J.J., Bell-McGinty S., Tang M.X., Schupf N., Stern Y., Mayeux R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch. Neurol. 2005, 62:1739-1746.
25. Morgan C.D., Nordin S., Murphy C. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J. Clin. Exp. Neuropsychol. 1995, 17(5):793-803.
26. Murphy C. Olfactory functional testing: sensitivity and specificity for Alzheimer's disease. Drug Dev. Res. 2002, 56:123-131.
27. Murphy C., Bacon A.W., Bondi M.W., Salmon D.P. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann. N. Y. Acad. Sci. 1998 Nov 30, 855:744-750.
28. Murphy C., Jernigan T.L., Fennema-Notestine C. Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. J. Int. Neuropsychol. Soc. 2003, 9(3):459-471.
29. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
30. Price J.L., Morris J.C. Tangles and plagues in nondemented aging and " preclinical" Alzheimer's disease. Ann. Neurol. 1999, 45:358-368.
31. Reyes P.F., Deems D.A., Suarez M.G. Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study. Brain Res. Bull. 1993, 32(1):1-5.
32. Serby M., Larson P., Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am. J. Psychiatry 1991, 148(3):357-360.
33. Stern M.B. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. The Comprehensive Management of Parkinson's Disease 1978, 34-39. PMA Publishing Corporation, New York. M.B. Stern, H.I. Hurtig (Eds.).
34. Stern Y., Andrews H., Pittman J., Sano M., Tatemichi T., Lantigua R., Mayeux R. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol. 1992, 49:453-460.
35. Swan G.E., Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002, 21:58-67.
36. Tabert M., Liu X., Doty R.L., Serby M., Zamora D., Pelton G.H., Marder K., Albers M.W., Stern Y., Devanand D.P. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann. Neurol. 2005, 58:155-160.
37. Tabert M.H., Manly J.J., Liu X., Pelton G.H., Rosenblum S., Jacobs M., Zamora D., Goodkind M., Bell K., Stern Y., Devanand D.P. Neuropsychological prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Arch. Gen. Psychiatry 2006, 63:916-924.
38. Wang J., Eslinger P.J., Smith M.B., Yang Q.X. Functional magnetic resonance imaging study of human olfaction and normal aging. J. Gerontol. A. Biol. Sci. Med. Sci. 2005, 60:510-514.
39. Westervelt H.J., Carvalho J., Duff K. Presentation of Alzheimer's disease in patients with and without olfactory deficits. Arch. Clin. Neuropsychol. 2007, 22(1):117-122.
40. Wiebe S.P., Staubli U.V. Recognition memory correlates of hippocampal theta cells. J. Neurosci. 2001, 21(11):3955-3967.
41. Wilson R.S., Arnold S.E., Schneider J.A., Tang Y., Bennett D.A. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J. Neurol. Neurosurg. Psychiatry 2007, 78:30-35.
42. Wilson R.S., Schneider J.A., Arnold S.E., Tang Y., Boyle P.A., Bennett D.A. Olfactory identification and incidence of mild cognitive impairment in older age. Arch. Gen. Psychiatry 2007, 64(7):802-808.
43. Yousem D.M., Maldjian J.A., Siddiqi F., Hummel T., Alsop D.C., Geckle R.J., Bilker W.B., Doty R.L. Gender effects on odor-stimulated functional magnetic resonance imaging. Brain Res. 1999, 818(2):480-487.
44. Zald D.H., Pardo J.V. Functional neuroimaging of the olfactory system in humans. Int. J. Psychophysiol. 2000, 36(2):165-181.